Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Diosmin 600mg for Painful Symptoms in Chronic Venous Disease
NCT01532882Phase 3Completed
- Sponsor
- InnoTech Precision Medicine
- Start
- Jan 2012
- Primary completion
- Mar 2013
- Modality
- Covalent Small Molecules, Classical Binding Small Molecules, Nucleic Acid-Directed Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of diosmin in chronic venous disease (CVD), sponsored by InnoTech Precision Medicine. Started Jan 2012; status: completed.
02
Drugs
diosmin
03
Conditions
chronic venous disease (CVD)
Beyond the preview
Go deeper on NCT01532882.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01532882.